NCT03709134View on ClinicalTrials.gov

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Breast CancerBreast NeoplasmsCancer, Breast
Interventions
DIAGNOSTIC_TEST

Genomic Markers (CTC/ctDNA)

This is a non-interventional study.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03709134 - Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter